iShares iBoxx $ High Yield Corporate Bd (HYG)
The investment seeks the results that correspond generally to the price and yield performance, before fees and expenses, of the iBoxx $ Liquid High Yield index. The index is a rules-based index consisting of the most liquid and tradable U.S. dollar-denominated, high-yield corporate bonds for sale in the U.S. The fund is non-diversified.
HYG Weekly Trend Model
The Trend Model captured the bulk of the monthly dividends (about 10% annually) over the course of the past 15 months, while side-stepping two periods of price instability. Adding the capital gains to the dividend, the total return shown above was about 30%, or about 2% per month. That is not a gurantee of future performance, but it did get my attention and HYG is a viable candidate for inclusion in the Basket of Income.
2 comments:
http://finance.yahoo.com/news/MDRNA-agrees-to-buy-Cequent-apf-2146712284.html?x=0&.v=1
news on MRNA
Bigger MRNA news:
Dec. 10 /PRNewswire/ -- Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) approved Cequent's first IND (investigational new drug) application yesterday.
Post a Comment